Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HYTHIAM INC | 200,000 | reported | 17 Feb 2015 | tx 2+350,000 |
| SELLAS Life Sciences Group, Inc. | 100,000 | reported | 19 Jun 2015 | tx 111+1,939,584−1,409,584 |
| BRADLEY PHARMACEUTICALS INC | 30,000 | reported | 21 Feb 2008 | tx 20+40,000−60,000 |
| CYTRX CORP | 0 | reported | 07 Aug 2020 | tx 33+20,979,364−6,164,179 |
| AUTHENTIDATE HOLDING CORP | 0 | reported | 17 Feb 2004 | tx 6+30,000−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Aug 2020 | TAX_WITHHOLDING | CYTRX CORP | 1,164,179 | 0.67 USD | |
| 07 Aug 2020 | EXERCISE | CYTRX CORP | 3,000,000 | 0.26 USD | |
| 07 Aug 2020 | EXERCISE | CYTRX CORP | 3,000,000 | 0.00 USD | deriv |
| 13 Dec 2019 | GRANT_AWARD | CYTRX CORP | 3,000,000 | 0.00 USD | deriv |
| 15 Dec 2017 | GRANT_AWARD | CYTRX CORP | 387,597 | 1.75 USD | |
| 15 Dec 2017 | GRANT_AWARD | CYTRX CORP | 208,334 | 0.00 USD | deriv |
| 15 Dec 2016 | GRANT_AWARD | CYTRX CORP | 2,325,581 | 0.43 USD | |
| 15 Dec 2016 | GRANT_AWARD | CYTRX CORP | 1,250,000 | 0.00 USD | deriv |
| 15 Dec 2016 | GRANT_AWARD | CYTRX CORP | 1,250,000 | 0.00 USD | deriv |
| 15 Dec 2015 | GRANT_AWARD | CYTRX CORP | 1,000,000 | 0.00 USD | deriv |
| 19 Jun 2015 | GRANT_AWARD | SELLAS Life Sciences Group, Inc. | 100,000 | 0.00 USD | deriv |
| 17 Feb 2015 | GRANT_AWARD | HYTHIAM INC | 200,000 | 0.00 USD | deriv |
| 15 Dec 2014 | GRANT_AWARD | CYTRX CORP | 600,000 | 0.00 USD | deriv |
| 23 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 100,000 | 1.18 USD | |
| 23 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 50,000 | 2.31 USD | |
| 23 Jan 2014 | SALE | SELLAS Life Sciences Group, Inc. | 150,000 | 5.92 USD | anomaly |
| 23 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 100,000 | 0.00 USD | deriv |
| 23 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 50,000 | 0.00 USD | deriv |
| 22 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 200,000 | 1.18 USD | |
| 17 Jan 2014 | SALE | SELLAS Life Sciences Group, Inc. | 200,000 | 7.00 USD | anomaly |
| 17 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 200,000 | 0.85 USD | |
| 22 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 50,000 | 0.72 USD | |
| 22 Jan 2014 | SALE | SELLAS Life Sciences Group, Inc. | 250,000 | 6.13 USD | anomaly |
| 22 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 50,000 | 0.00 USD | deriv |
| 17 Jan 2014 | EXERCISE | SELLAS Life Sciences Group, Inc. | 200,000 | 0.00 USD | deriv |